FITMX
Price
$17.93
Change
+$0.03 (+0.17%)
Updated
Oct 17 closing price
Net Assets
912.16M
RERAX
Price
$60.79
Change
-$0.26 (-0.43%)
Updated
Oct 17 closing price
Net Assets
137.72B
Interact to see
Advertisement

FITMX vs RERAX

Header iconFITMX vs RERAX Comparison
Open Charts FITMX vs RERAXBanner chart's image
Fidelity SAI International Mtm Idx
Price$17.93
Change+$0.03 (+0.17%)
VolumeN/A
Net Assets912.16M
American Funds EUPAC R1
Price$60.79
Change-$0.26 (-0.43%)
VolumeN/A
Net Assets137.72B
FITMX vs RERAX Comparison Chart in %
View a ticker or compare two or three
VS
FITMX vs. RERAX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FITMX is a Hold and RERAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RERAX has more cash in the bank: 138B vs. FITMX (912M). FITMX pays higher dividends than RERAX: FITMX (2.66) vs RERAX (0.22). FITMX was incepted earlier than RERAX: FITMX (5 years) vs RERAX (23 years). RERAX (1.57) is less costly to investors than FITMX (0.18). FITMX is a more actively managed with annual turnover of: 62.00 vs. RERAX (35.00). FITMX has a lower initial minimum investment than RERAX: FITMX (0) vs RERAX (250). FITMX annual gain was more profitable for investors over the last year : 24.28 vs. RERAX (10.31). FITMX return over 5 years is better than : 69.34 vs. RERAX (9.89).
FITMXRERAXFITMX / RERAX
Total Expense Ratio0.181.5711%
Annual Report Gross Expense Ratio0.181.5711%
Fund Existence5 years23 years-
Gain YTD31.23221.059148%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets912M138B1%
Annual Yield % from dividends2.660.221,202%
Returns for 1 year24.2810.31235%
Returns for 3 years96.1846.07209%
Returns for 5 years69.349.89701%
Returns for 10 yearsN/A36.02-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GAP21.600.95
+4.60%
Gap Inc (The)
PCAPU10.55-0.09
-0.80%
Procap Acquisition Corp
BRNS1.33-0.02
-1.33%
Barinthus Biotherapeutics plc
JANX26.76-0.44
-1.62%
Janux Therapeutics
NVEC71.97-1.42
-1.93%
NVE Corp